CONMED Corporation
CNMD
$58.29
-$0.6278-1.07%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.00% | 10.23% | 12.02% | 14.83% | 19.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.00% | 10.23% | 12.02% | 14.83% | 19.06% |
| Cost of Revenue | 2.61% | 6.70% | 8.71% | 12.26% | 18.75% |
| Gross Profit | 6.94% | 13.18% | 14.79% | 16.97% | 19.31% |
| SG&A Expenses | 2.60% | 6.42% | 7.12% | 11.12% | 15.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.65% | 6.67% | 7.85% | 11.61% | 17.11% |
| Operating Income | 25.51% | 47.82% | 59.62% | 50.56% | 39.26% |
| Income Before Tax | 101.70% | 440.63% | 394.82% | 220.89% | 214.07% |
| Income Tax Expenses | 86.96% | 199.88% | 140.01% | 172.44% | 68.40% |
| Earnings from Continuing Operations | 105.44% | 127.25% | 11.68% | 187.85% | 179.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 105.44% | 127.25% | 11.68% | 187.85% | 179.99% |
| EBIT | 25.51% | 47.82% | 59.62% | 50.56% | 39.26% |
| EBITDA | 16.63% | 28.71% | 34.45% | 29.94% | 24.39% |
| EPS Basic | 104.60% | 125.66% | 10.69% | 183.55% | 176.10% |
| Normalized Basic EPS | 39.08% | 82.46% | 102.01% | 90.10% | 51.32% |
| EPS Diluted | 107.80% | 126.86% | 10.75% | 180.44% | 172.09% |
| Normalized Diluted EPS | 41.73% | 85.20% | 103.22% | 87.68% | 56.18% |
| Average Basic Shares Outstanding | 0.57% | 0.66% | 0.79% | 1.40% | 2.09% |
| Average Diluted Shares Outstanding | -1.23% | -0.50% | 0.43% | 2.64% | -0.61% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.51% | -0.56% | -0.10% | 2.16% | 2.28% |
